Coridon, a company focused on developing next generation DNA vaccines, was founded by Professor Ian Frazer, Australian of the Year 2006. Prof Frazer is well recognised for his groundbreaking research that led to Merck & Co.’s highly successful cervical cancer vaccine, Gardasil®.
Through Coridon, Prof Frazer is working to expand his success with Gardasil by developing vaccines from patented technology that can be applied to a range of infectious diseases in humans.
Coridon’s technology has the potential to lead to the development of vaccines that aid in both the prevention of initial infection (traditional vaccine); and the treatment of those already infected (therapeutic vaccine).
Prof Frazer’s team already has a proven track record in pioneering cancer vaccines and the work now being undertaken is expected to result in the development of DNA vaccines that have the ability to improve the quality of life of patients across the world.
Coridon was established in 2000 to undertake the commercialisation of outcomes from Prof Frazer’s work. Allied Medical acquired the rights to a majority shareholding in Coridon in 2008.